Sinil Pharmaceutical Co. Ltd (012790) — Long-term Investment Intensity
Sinil Pharmaceutical Co. Ltd (012790) has a Long-term Investment Intensity of 1.3% as of December 2019. Long-term investments of ₩1.52 Billion represent 1.3% of total assets of ₩117.84 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Sinil Pharmaceutical Co. Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sinil Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Sinil Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 1.3%, reflecting long-term investments of ₩1.52 Billion against total assets of ₩117.84 Billion KRW. For the complete balance sheet picture, see total assets of Sinil Pharmaceutical Co. Ltd.
Annual Long-term Investment Intensity for Sinil Pharmaceutical Co. Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Sinil Pharmaceutical Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 012790 liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.3% | ₩1.52 Billion | ₩117.84 Billion | ▲ +1.3 pp |
| 2018 | 0.0% | ₩34.37 Million | ₩106.40 Billion | ▼ -0.1 pp |
| 2017 | 0.2% | ₩185.02 Million | ₩102.52 Billion | ▼ 0.0 pp |
| 2016 | 0.2% | ₩214.59 Million | ₩98.05 Billion | ▼ -0.2 pp |
| 2015 | 0.4% | ₩348.32 Million | ₩87.26 Billion | ▼ -0.4 pp |
| 2014 | 0.8% | ₩606.52 Million | ₩79.91 Billion | — |